Log in to save to my catalogue

Immunogenicity and Protective Efficacy against Murine Tuberculosis of a Prime-Boost Regimen with BCG...

Immunogenicity and Protective Efficacy against Murine Tuberculosis of a Prime-Boost Regimen with BCG...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_859914605

Immunogenicity and Protective Efficacy against Murine Tuberculosis of a Prime-Boost Regimen with BCG and a DNA Vaccine Expressing ESAT-6 and Ag85A Fusion Protein

About this item

Full title

Immunogenicity and Protective Efficacy against Murine Tuberculosis of a Prime-Boost Regimen with BCG and a DNA Vaccine Expressing ESAT-6 and Ag85A Fusion Protein

Publisher

Cairo, Egypt: Hindawi Puplishing Corporation

Journal title

Clinical & developmental immunology, 2011-01, Vol.2011 (2011), p.1-10

Language

English

Formats

Publication information

Publisher

Cairo, Egypt: Hindawi Puplishing Corporation

More information

Scope and Contents

Contents

Heterologous prime-boost regimens utilizing BCG as a prime vaccine probably represent the best hope for the development of novel tuberculosis (TB) vaccines. In this study, we examined the immunogenicity and protective efficacy of DNA vaccine (pcD685A) expressing the fusion protein of Ag85A and ESAT-6 (r685A) and its booster effects in BCG-immunized...

Alternative Titles

Full title

Immunogenicity and Protective Efficacy against Murine Tuberculosis of a Prime-Boost Regimen with BCG and a DNA Vaccine Expressing ESAT-6 and Ag85A Fusion Protein

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_859914605

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_859914605

Other Identifiers

ISSN

1740-2522,2314-8861

E-ISSN

1740-2530,2314-7156

DOI

10.1155/2011/617892

How to access this item